<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Three-center feasibility of lung clearance index in infants and preschool children with cystic fibrosis and other lung diseases</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-08-12">12 August 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Mirjam</forename><surname>Stahl</surname></persName>
							<email>mirjam.stahl@med.uni-heidelberg.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatrics</orgName>
								<orgName type="laboratory">Division of Pediatric Pulmonology and Allergy and Cystic Fibrosis Center</orgName>
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 430</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Translational Pulmonology</orgName>
								<orgName type="department" key="dep2">Translational Lung Research Center Heidelberg (TLRC)</orgName>
								<orgName type="department" key="dep3">German Centre for Lung Research (DZL)</orgName>
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 156</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Simon</forename><forename type="middle">Y</forename><surname>Graeber</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatrics</orgName>
								<orgName type="laboratory">Division of Pediatric Pulmonology and Allergy and Cystic Fibrosis Center</orgName>
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 430</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Translational Pulmonology</orgName>
								<orgName type="department" key="dep2">Translational Lung Research Center Heidelberg (TLRC)</orgName>
								<orgName type="department" key="dep3">German Centre for Lung Research (DZL)</orgName>
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 156</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Cornelia</forename><surname>Joachim</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatrics</orgName>
								<orgName type="laboratory">Division of Pediatric Pulmonology and Allergy and Cystic Fibrosis Center</orgName>
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 430</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Translational Pulmonology</orgName>
								<orgName type="department" key="dep2">Translational Lung Research Center Heidelberg (TLRC)</orgName>
								<orgName type="department" key="dep3">German Centre for Lung Research (DZL)</orgName>
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 156</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sandra</forename><surname>Barth</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Pediatrics</orgName>
								<orgName type="institution">Justus-Liebig-University Giessen</orgName>
								<address>
									<addrLine>Feulgenstrasse 10-12</addrLine>
									<postCode>35392</postCode>
									<settlement>Giessen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Marburg Lung Centre (UGMLC)</orgName>
								<orgName type="laboratory">German Centre for Lung Research (DZL)</orgName>
								<orgName type="institution">Universities Giessen</orgName>
								<address>
									<addrLine>Aulweg 130</addrLine>
									<postCode>35392</postCode>
									<settlement>Giessen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Isabell</forename><surname>Ricklefs</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Pediatric Allergology and Pneumology</orgName>
								<orgName type="institution">Medical University of Lübeck</orgName>
								<address>
									<addrLine>Ratzeburger Allee 160</addrLine>
									<postCode>23538</postCode>
									<settlement>Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Airway Research Centre North (ARCN)</orgName>
								<orgName type="laboratory">German Centre for Lung Research (DZL)</orgName>
								<address>
									<addrLine>Ratzeburger Allee 160</addrLine>
									<postCode>23538</postCode>
									<settlement>Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gesa</forename><surname>Diekmann</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Pediatric Allergology and Pneumology</orgName>
								<orgName type="institution">Medical University of Lübeck</orgName>
								<address>
									<addrLine>Ratzeburger Allee 160</addrLine>
									<postCode>23538</postCode>
									<settlement>Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Airway Research Centre North (ARCN)</orgName>
								<orgName type="laboratory">German Centre for Lung Research (DZL)</orgName>
								<address>
									<addrLine>Ratzeburger Allee 160</addrLine>
									<postCode>23538</postCode>
									<settlement>Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Matthias</forename><forename type="middle">V</forename><surname>Kopp</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Pediatric Allergology and Pneumology</orgName>
								<orgName type="institution">Medical University of Lübeck</orgName>
								<address>
									<addrLine>Ratzeburger Allee 160</addrLine>
									<postCode>23538</postCode>
									<settlement>Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Airway Research Centre North (ARCN)</orgName>
								<orgName type="laboratory">German Centre for Lung Research (DZL)</orgName>
								<address>
									<addrLine>Ratzeburger Allee 160</addrLine>
									<postCode>23538</postCode>
									<settlement>Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lutz</forename><surname>Naehrlich</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Pediatrics</orgName>
								<orgName type="institution">Justus-Liebig-University Giessen</orgName>
								<address>
									<addrLine>Feulgenstrasse 10-12</addrLine>
									<postCode>35392</postCode>
									<settlement>Giessen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Marburg Lung Centre (UGMLC)</orgName>
								<orgName type="laboratory">German Centre for Lung Research (DZL)</orgName>
								<orgName type="institution">Universities Giessen</orgName>
								<address>
									<addrLine>Aulweg 130</addrLine>
									<postCode>35392</postCode>
									<settlement>Giessen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marcus</forename><forename type="middle">A</forename><surname>Mall</surname></persName>
							<email>marcus.mall@med.uni-heidelberg.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatrics</orgName>
								<orgName type="laboratory">Division of Pediatric Pulmonology and Allergy and Cystic Fibrosis Center</orgName>
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 430</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Translational Pulmonology</orgName>
								<orgName type="department" key="dep2">Translational Lung Research Center Heidelberg (TLRC)</orgName>
								<orgName type="department" key="dep3">German Centre for Lung Research (DZL)</orgName>
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 156</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Department of Pediatric Pulmonology and Immunology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Division of Pediatric Pulmonology &amp; Allergy and CF Center</orgName>
								<orgName type="department" key="dep2">Department of Translational Pulmonology</orgName>
								<orgName type="department" key="dep3">Translational Lung Research Center Heidelberg (TLRC)</orgName>
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 430</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Department of Translational Pulmonology and Division of Pediatric Pulmonology &amp; Allergy and CF Center</orgName>
								<orgName type="department" key="dep2">Translational Lung Research Center Heidelberg (TLRC)</orgName>
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 430</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Three-center feasibility of lung clearance index in infants and preschool children with cystic fibrosis and other lung diseases</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-08-12">12 August 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">035838D8709642B744D14F09C3C6157F</idno>
					<idno type="DOI">10.1016/j.jcf.2017.08.001</idno>
					<note type="submission">Received 15 May 2017; revised 28 July 2017; accepted 1 August 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:49+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Lung clearance index</term>
					<term>Multiple breath washout</term>
					<term>Infant lung function test</term>
					<term>Early CF lung disease</term>
					<term>Clinical trial endpoint</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Lung clearance index (LCI) detects early ventilation inhomogeneity and has been suggested as sensitive endpoint in multicenter intervention trials in infants and preschoolers with cystic fibrosis (CF).</s><s>However, the feasibility of multicenter LCI in this age group has not been determined.</s><s>We, therefore, investigated the feasibility of LCI in infants and preschoolers with and without CF in a three-center setting.</s><s>Methods: Following central training, standardized SF 6 -MBW measurements were performed in 73 sedated children (10 controls, 49 with CF and 14 with other lung diseases), mean age 2.3 ± 1.2 years across three centers, and data were analyzed centrally.</s><s>Results: Overall success rate of LCI measurements was 91.8% ranging from 78.9% to 100% across study sites.</s><s>LCI was increased in patients with CF (P b 0.05) and with other lung diseases (P b 0.05) compared to controls.</s><s>Conclusion: Our results support feasibility of LCI as multicenter endpoint in clinical trials in infants and preschoolers with CF.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p><s>Early onset and progression of lung disease starting in the first months of life remains the leading cause of morbidity and mortality in patients with cystic fibrosis (CF) suggesting that early therapeutic intervention may be most beneficial <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>Therefore, quantitative non-invasive endpoints sensitive to detect early lung abnormalities and disease progression in multicenter studies are warranted for clinical testing of preventive therapies in infants and preschool children with CF <ref type="bibr" target="#b2">[3]</ref>.</s><s>In addition to work focusing on infant pulmonary function tests (PFT) and imaging by chest CT and MRI as outcome measures in this age group <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref>, emerging evidence suggests that lung clearance index (LCI) derived from multiple-breath washout (MBW) may be a suitable outcome measure for this purpose.</s><s>First, a series of single center studies demonstrated that LCI detects ventilation inhomogeneity and response to therapeutic interventions such as inhaled hypertonic saline and Dornase alpha in school age children with normal spirometry, as well as preschool children and infants with CF <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref>.</s><s>Further, LCI has been used in observational studies across two sites by the Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF) <ref type="bibr" target="#b15">[16]</ref>.</s><s>Recently, LCI was shown to be feasible and sensitive to detect disease progression in preschool children with CF and response to CFTR modulator therapy in school age children with CF in multicenter trials <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref>.</s><s>However, data on multicenter feasibility of MBW in infants and preschool children with CF including study centers naïve to this technique is lacking.</s><s>Further, in contrast to older children where MBW can be performed without sedation by inhalation of 100% oxygen to washout nitrogen (N 2 ) from the lungs, measurements in infants and young preschool children require sedation to ensure cooperativity and the use of tracer gases such as sulfur hexafluoride (SF 6 ) to avoid alterations of the breathing pattern induced by exposure to pure oxygen in this age group <ref type="bibr" target="#b19">[20]</ref>.</s><s>These factors make LCI measurements in infants and young preschool children more demanding and may hamper the feasibility of multicenter trials.</s></p><p><s>The aim of this study was, therefore, to implement and validate a standardized multicenter SF 6 MBW protocol in sedated infants and preschool children and determine the feasibility of LCI as an outcome measure of early CF lung disease in the clinical trial network of the German Center for Lung Research (DZL) in preparation of an early intervention trial in this age group (ClinicalTrials.gov</s><s>Identifier: NCT01619657).</s><s>We conducted central and local training of the study site members and measurements were performed in infants and preschool children with CF, healthy controls and age-matched children with other lung diseases following a standardized MBW protocol under supervision of the central MBW lab with central data analysis and prompt feedback for troubleshooting.</s><s>Results on feasibility of successful MBW measurements and LCI values were compared between the participating centers and study groups.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.">Study population</head><p><s>This prospective multicenter validation study was coordinated by the Translational Lung Research Center Heidelberg (TLRC) and conducted across 3 sites of the DZL, a multi-site national research center established to develop new approaches for prevention, diagnosis and therapy of severe lung diseases including CF <ref type="bibr" target="#b20">[21]</ref>.</s><s>The study was approved by the Ethics Committee of the University Hospital Heidelberg (coordinating center) and the local Ethics Committees of all participating sites.</s><s>Parents obtained detailed information on the study protocol including sedation and gave their signed informed consent.</s><s>In total, 73 infants and preschool children (mean age 2.3 ± 1.2 years; range 0.0-5.1 years), including 49 patients with CF, 14 patients with other lung diseases and 10 healthy controls were prospectively recruited.</s><s>The group of patients with other lung diseases included primary ciliary dyskinesia (n = 1), hemophagocytic lymphohistiocytosis (n = 1), chronic kidney disease stage 5 with recurrent respiratory infections (n = 2), immunodeficiency (n = 2), bronchiolitis obliterans (n = 1), recurrent obstructive bronchitis (n = 2), status post pneumonia (n = 1), status post pneumothorax (n = 1), congenital pulmonary airway malformation (n = 1), prematurity (n = 1), and hypoplasia of right upper lobe (n = 1).</s><s>Demographics of the study population are summarized in Table <ref type="table" target="#tab_0">1</ref>.</s><s>Z-scores for weight, height and BMI were derived from reference values of healthy children in Germany <ref type="bibr" target="#b21">[22,</ref><ref type="bibr" target="#b22">23]</ref>.</s><s>Details on CFTR genotypes of patients with CF, diagnoses in patients with other lung diseases, and information on indications for sedation and how lung disease was excluded in the healthy control group are available in the online supplement.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Multiple breath washout test</head><p><s>MBW measurements were established at TLRC before the start of this study <ref type="bibr" target="#b10">[11]</ref>.</s><s>At the Airway Research Center North (ARCN) and the Universities of Giessen and Marburg Lung Center (UGMLC), MBW measurements in infants were established during this study.</s><s>Children were sedated with oral or rectal chloral hydrate (100 mg/kg body weight, maximum dose of 2 g) as per guidelines <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b24">25]</ref> and MBW testing was performed using the infant setup of a commercially available mainstream ultrasonic flowmeter (Exhalyzer D, Eco Medics, Duernten, Switzerland) with SF 6 as tracer gas and the child lying in supine position as previously described <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b25">26]</ref>.</s><s>Details on performance of MBW are provided in the online supplement.</s><s>Abnormal LCI was defined as above 7.4, the upper limit of normal (ULN) from previously investigated non-CF controls without lung disease <ref type="bibr" target="#b10">[11]</ref>.</s><s>A successful investigation was defined as any MBW measurement with two or more technically acceptable washout curves in the set <ref type="bibr" target="#b26">[27]</ref>.</s><s>The following requirements were pre-specified and had to be fulfilled by DZL sites prior to inclusion in the study: i) availability of an Exhalyzer D (Eco Medics, Duernten, Switzerland) with infant set up, ii) availability of the tracer gas mixture with 4% SF 6 , and iii) routine sedation with chloral hydrate for diagnostic procedures.</s><s>The CF centers at the five DZL sites were invited to submit feasibility questionnaires for the evaluation of these prespecified criteria and technical specifications of MBW hardware and software versions installed.</s><s>Specifications were reviewed within 4 weeks and three DZL sites including the ARCN, the TLRC and the UGMLC fulfilled all criteria and were selected as study sites.</s><s>Following this selection process, a datasheet containing the standardized MBW protocol and the data acquisition and analysis software version installed at the coordinating center in Heidelberg (WBreath version 2.0.0.0, ndd Medical Technologies, Zurich, Switzerland) were distributed and the study team at each site was instructed to install this software version on their MBW PC.</s></p><formula xml:id="formula_0">− 0.3 ± 1.0 − 0.8 ± 0.8 − 0.7 ± 1.4 Height z-score − 1.3 ± 1.2 − 1.1 ± 1.3 − 1.2 ± 1.8 BMI z-score 0.4 ± 1.5 − 0.4 ± 1.0 ⁎ − 0.4 ± 1.5 F508del/F508del,</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.2.">Pre-study training session</head><p><s>Prior to the start of the study, a dedicated training session on acquisition of the MBW study protocol and on systematic washout interpretation was held at the coordinating site at Heidelberg.</s><s>Members of all participating sites attended this teaching session.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.3.">Implementation of the MBW protocol at study sites</head><p><s>Initiation of each study site was individually supported by the coordinating center by a team of three experts (MS, CJ, SYG).</s><s>Initiation visits were held at each site and all personnel (lung function technicians, pediatricians, study nurses) involved in the study were trained with regard to the standard operating procedure (SOP) of MBW protocol including calibration of the MBW machine, performing standardized MBW measurements in infants and preschool children, as well as organizational procedures and management of acquired data such as pseudonymization and transfer of MBW files for central evaluation to the coordinating center.</s><s>The previously installed MBW software was checked, corrections were made as necessary and a supervised MBW measurement was carried out on site to ensure standardized execution and quality.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.4.">Data management and central assessment</head><p><s>A pediatrician trained in MBW performance and analysis at the respective study site evaluated the MBW tracings diagnostically and reported findings to the parents.</s><s>MBW files were pseudonymized and sent to the coordinating center for central quality control, evaluation and statistical analysis.</s><s>Reports of central analyses were fed back to the study sites to improve their experience in interpretation of diagnostic MBW measurements.</s><s>MBW data were analyzed by an experienced reader (MS) specialized in pediatric lung function testing with the same software version.</s><s>For analysis of LCI, only results of children with at least two successful washout curves fulfilling quality criteria were used <ref type="bibr" target="#b26">[27]</ref>.</s><s>Files were corrected following a previously described new algorithm <ref type="bibr" target="#b27">[28,</ref><ref type="bibr" target="#b28">29]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.">Statistical analysis</head><p><s>Data were analyzed using SPSS version 21.0 (SPSS Inc., Chicago, IL, USA) and are shown as mean ± SD or percentage, if not indicated otherwise.</s><s>For categorical data, groups were compared with Fisher's exact test and for continuous data with unpaired Student's t-test or ANOVA and post-hoc Bonferroni test.</s><s>Associations between LCI, age and anthropometric values were assessed by scatter plot and linear regression with determination of the Pearson correlation coefficient <ref type="bibr" target="#b29">[30]</ref>.</s><s>A P value of b 0.05 was accepted to indicate statistical significance.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.">Feasibility of three-center LCI in infants and preschool children</head><p><s>To determine the feasibility of three-center LCI, we performed MBW measurements in a total of 73 sedated infants and preschool children (Table <ref type="table" target="#tab_0">1</ref>) across three sites of the DZL (ARCN, TLRC and UGMLC).</s><s>Demographics of the three study groups were similar except a lower BMI z-score in CF patients compared to controls (Table <ref type="table" target="#tab_0">1</ref>).</s><s>Multicenter MBW measurements were performed according to a standardized protocol using SF 6 as tracer gas in supine position with a face mask as interface.</s><s>Sedation with chloral hydrate was successful in all children without adverse effects (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s>At TLRC where SF 6 -MBW was implemented in this age group prior to this study <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref>, all attempts were successful (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s>At ARCN and UGMLC, where MBW in infants and preschool children was implemented during this study, overall success rates were 78.9% and 87.5%, respectively (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s>The success rates at these two sites previously naïve to SF 6 -MBW in this age group were higher than results obtained in a prior single center implementation study at TLRC with an overall success rate of 67.5% <ref type="bibr" target="#b10">[11]</ref>.</s><s>Overall, multicenter MBW investigations in the present study were successful in 67 of 73 infants and preschool children resulting in a success rate of 91.8% (Fig. <ref type="figure" target="#fig_0">1</ref>).</s></p><p><s>Comparison of the total number of MBW attempts across study sites and study groups revealed no differences except a lower number of attempts in infants and preschool children with other lung diseases at ARCN compared to TLRC (Table <ref type="table" target="#tab_2">2</ref>).</s><s>The number of successful attempts was lower at ARCN compared to TLRC in patients with CF and with other lung diseases (Table <ref type="table" target="#tab_2">2</ref>).</s><s>On average, across all study sites and study groups, 3.4 attempts were performed to gain at least two washout curves per child fulfilling quality criteria (Table <ref type="table" target="#tab_2">2</ref>).</s><s>Overall, more attempts were performed in children with CF (3.6 ± 1.2) compared to the control group (3.1 ± 0.3; P b 0.05) or patients with other lung diseases (3.0 ± 0.6; P b 0.01).</s><s>However, this higher number of attempts was not always necessary to obtain two successful measurements and was mainly performed for training purposes in this implementation study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.">Reasons for unsuccessful MBW measurements</head><p><s>The reasons for unsuccessful MBW investigations (b 2 washout curves fulfilling quality criteria) in our study were recurrent sighs (n = 3 children) and technical problems (n = 3 children).</s><s>In some infants and preschool children, at least two washout curves fulfilled quality criteria thus qualifying as successful investigation, but further MBW measurements of the same set did not meet acceptability criteria due to i) differences in FRC and/or LCI N 10% (in 3 or more traces) or 5% (in 2 traces) (n = 8 children), ii) recurrent sighs (n = 2 children), iii) leaks (n = 1 child) and technical problems (n = 1 child).</s><s>At least one acceptable washout curve was obtained in 93.2% (Table <ref type="table" target="#tab_2">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.">Three-center LCI in infants and preschool children with CF, other lung diseases and controls</head><p><s>The mean absolute LCI in infants and preschool children of the control group was 6.6 ± 0.4 (Fig. <ref type="figure" target="#fig_1">2</ref>).</s><s>In the CF group, the mean LCI was significantly increased to 7.3 ± 1.2 (P b 0.05) (Fig. <ref type="figure" target="#fig_1">2</ref>).</s><s>The mean LCI was also elevated in infants and preschool children with other lung diseases (7.2 ± 1.0; P b 0.05 vs. controls) (Fig. <ref type="figure" target="#fig_1">2</ref>).</s><s>Across all three study sites, 10 out of 43 (23.3%)</s><s>patients with CF with successful MBW measurements had an elevated LCI above 7.4, the ULN determined from a previous control group (Table <ref type="table" target="#tab_3">3</ref>) <ref type="bibr" target="#b10">[11]</ref>.</s><s>In infants and preschool children with other lung diseases, 4 out of 14 (28.6%) had an elevated LCI, whereas the remaining study population with successful MBW measurements including 33 CF patients, 10 patients with other lung diseases and all controls had a LCI below the ULN.</s><s>In all three groups (controls, CF, other lung diseases), the LCI did not correlate with age, gender, anthropometric values, or clinical symptoms such as cough.</s><s>Comparison of LCI data from infants and preschool children with CF obtained at individual study sites revealed no differences in the mean LCI (P = 0.287), coefficients of variation of the LCI (P = 0.689) or the frequency of patients with elevated LCI (P = 0.645) between the three study centers (Table <ref type="table" target="#tab_3">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Discussion</head><p><s>In contrast to other organs such as the pancreas, the lungs are structurally normal at birth in children with CF and early diagnosis by newborn screening has created a unique opportunity for early therapeutic intervention that may delay or ultimately prevent the onset of irreversible lung damage <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b31">32]</ref>.</s><s>Therefore, clinical trials testing this early intervention paradigm and outcome measures that are feasible and sensitive to detect early lung disease in infants and preschool children with CF in a multicenter setting are urgently needed.</s><s>In this context, previous studies focused on infant PFT and imaging by chest CT and MRI and the strengths and limitations of these techniques as outcome measures of lung disease in young children with CF were recently discussed elsewhere <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref>.</s><s>This study demonstrates for the first time that multicenter SF 6 -MBW is feasible in sedated infants and preschool children with CF and other lung diseases with high success rates.</s><s>Further, we show that the frequency and range of early ventilation inhomogeneity detected by multicenter LCI is comparable to previous single center studies in infants and preschool children with CF <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref>.</s><s>In addition, our study demonstrates that multicenter LCI can be established successfully in a clinical trial network containing study sites without prior experience in MBW in this challenging age group.</s><s>Collectively, these results support LCI as a promising non-invasive quantitative outcome measure for monitoring of early ventilation inhomogeneity in multicenter observational studies and as an endpoint in early intervention trials in infants and preschool children with CF.</s></p><p><s>Using an approach of central training, implementation of standard operating procedures and harmonized MBW protocols, continuous supervision and central MBW analysis to transfer methodology from a center with prior expertise in SF 6 -MBW in sedated infants and preschool children <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref> to study sites previously naïve to the technique, yielded high rates of technically acceptable MBW investigations across study groups (100% in controls; 87.8% in CF; 100% in other lung diseases) and study sites (78.9% at ARCN; 100% at TLRC; 87.5% at UGMLC) with an overall success rate of 91.8% (Fig. <ref type="figure" target="#fig_0">1</ref>; Table <ref type="table" target="#tab_2">2</ref>).</s><s>Of note these results are comparable to the feasibility of the raised-volume rapid thoracic compression (RVRTC) technique in sedated infants <ref type="bibr" target="#b32">[33]</ref>.</s><s>The two main factors contributing to unsuccessful MBW measurements in our study were i) technical problems with the Exhalyzer D not related to errors in calibration or performance of MBW; and ii) exchange of the investigator performing MBW with a new learning curve.</s><s>The latter observation indicates that, besides teaching and supervision, constancy of the study team is an important factor contributing to sustained success rates.</s><s>Compared to our results obtained in sedation, a recent study in unsedated preschool children demonstrated that success rates of MBW measurements were highly age-dependent and substantially lower (0-33%) in unsedated children under the age of 3 years <ref type="bibr" target="#b33">[34]</ref>.</s><s>This highlights the prerequisite of sedation to ensure feasibility of MBW measurements with success rates that are adequate and required for endpoints in clinical trials in this age group.</s></p><p><s>This study also has limitations.</s><s>Regarding the transferability of the high MBW success rates obtained in our study, it has to be noted that the DZL is a highly competent translational research network well equipped with experienced study site personnel.</s><s>This established infrastructure may have an important impact on feasibility and transferability of our results to a broader multicenter clinical trial setting.</s><s>Therefore, replication studies in larger networks, such as the ECFS-Clinical Trial Network or the CF Therapeutics Development Network will be necessary prior to using LCI as an outcome measure in multicenter clinical trials in infants and preschool children.</s><s>Ideally, these studies should also include longitudinal MBW measurements capturing the time points typically included in phase 3 clinical trials, i.e. at baseline, 1 month, 6 months and 12 months apart.</s><s>Another limitation of our study is the use of SF 6 as a tracer gas that is not available in all countries due to its classification as a greenhouse gas.</s><s>However, inhalation of pure oxygen that is required for nitrogen washout as an alternative to SF 6 induces altered breathing patterns in infants and at present, this issue remains unsolved <ref type="bibr" target="#b25">[26,</ref><ref type="bibr" target="#b34">35]</ref>.</s><s>Refined MBW protocols using either reduced SF 6 concentrations, alternative tracer gases or N 2 -MBW measurements with a priming phase to avoid abnormal breathing in infants are currently tested  and may solve this problem in the future.</s><s>In addition to limitations with availability of SF 6 as a tracer gas, chloral hydrate is not available in all countries for sedation of infants hampering applicability of the operating procedure validated in our study in such countries.</s></p><p><s>In summary, our study demonstrates that assessment of lung function by MBW is feasible with high success rates in sedated infants and preschool children with CF, other lung diseases and pulmonary healthy controls with a commercially available mainstream ultrasonic flowmeter.</s><s>Further, this study shows that the LCI is sensitive to detect abnormalities of lung function in infants and preschool children with CF and other lung diseases in a multicenter setting following initial training and supervision by a specialized pediatric lung function laboratory.</s><s>These results support the use of LCI not only for diagnostic monitoring of early lung disease, but as a potential non-invasive endpoint in early intervention clinical trials in patients with CF and possibly other genetic or acquired early onset lung diseases in a multicenter setting.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>Success rates of multicenter lung clearance index (LCI) measurements in sedated infants and preschool children without lung disease (control), with CF and with other lung diseases.</s><s>Summary of success rates for sufficient sedation and technically acceptable MBW studies for the total study population and for individual study sites.</s><s>Definition of abbreviations: ARCN, CF Center at Airway Research Center North.</s><s>TLRC, CF Center at Translational Lung Research Center Heidelberg.</s><s>UGMLC, CF Center at Universities of Giessen and Marburg Lung Center.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2. Summary of multicenter lung clearance index (LCI) in infants and preschool children without lung disease (control), with CF and with other lung diseases.</s><s>Dotted line represents upper limit of normal (ULN) of 7.4.</s><s>Open circles (ARCN, CF Center at Airway Research Center North), closed circles (TLRC, CF Center at Translational Lung Research Center Heidelberg) and triangles (UGMLC, CF Center at Universities of Giessen and Marburg Lung Center) represent data from individual children from the respective study site, horizontal lines represent mean values for each group.</s><s>*P b 0.05 vs. control group.</s></p></div></figDesc><graphic coords="5,81.30,70.13,173.48,169.74" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 Demographics of study population.</head><label>1</label><figDesc></figDesc><table><row><cell></cell><cell>Controls</cell><cell>CF</cell><cell>Other lung</cell></row><row><cell></cell><cell></cell><cell></cell><cell>diseases</cell></row><row><cell>Number of children, total</cell><cell>10</cell><cell>49</cell><cell>14</cell></row><row><cell>ARCN</cell><cell>0</cell><cell>12</cell><cell>7</cell></row><row><cell>TLRC</cell><cell>10</cell><cell>21</cell><cell>7</cell></row><row><cell>UGMLC</cell><cell>0</cell><cell>16</cell><cell>0</cell></row><row><cell>Age, yr (range)</cell><cell>2.4 ± 1.3</cell><cell>2.4 ± 1.1</cell><cell>1.7 ± 1.1</cell></row><row><cell></cell><cell>(0.7-4.0)</cell><cell>(0.2-5.1)</cell><cell>(0.0-3.6)</cell></row><row><cell>Sex, n (males/females)</cell><cell>5/5</cell><cell>20/29</cell><cell>9/5</cell></row><row><cell>Weight z-score</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2</head><label>2</label><figDesc><div><p><s>Success rates of MBW measurements in sedated infants and preschool children.</s></p></div></figDesc><table><row><cell>Center</cell><cell cols="3">All infants and preschool children</cell><cell>Controls</cell><cell>CF</cell><cell></cell><cell></cell><cell cols="2">Other lung diseases</cell></row><row><cell></cell><cell>ARCN</cell><cell>TLRC</cell><cell>UGMLC</cell><cell>TLRC</cell><cell>ARCN</cell><cell>TLRC</cell><cell>UGMLC</cell><cell>ARCN</cell><cell>TLRC</cell></row><row><cell>Studied population, n (% of all)</cell><cell>19 (26.0)</cell><cell>38 (52.1)</cell><cell>16 (21.9)</cell><cell>10 (13.7)</cell><cell>12 (16.4)</cell><cell>21 (28.8)</cell><cell>16 (21.9)</cell><cell>7 (9.6)</cell><cell>7 (9.6)</cell></row><row><cell>At least one successful washout, n (%)</cell><cell>16 (84.2)</cell><cell>38 (100)</cell><cell>14 (87.5)</cell><cell>10 (100)</cell><cell>9 (75.0)</cell><cell>21 (100)</cell><cell>14 (87.5)</cell><cell>7 (100)</cell><cell>7 (100)</cell></row><row><cell>At least two successful washouts, n (%)</cell><cell>15 (78.9)</cell><cell>38 (100)</cell><cell>14 (87.5)</cell><cell>10 (100)</cell><cell>8 (66.7)</cell><cell>21 (100)</cell><cell>14 (87.5)</cell><cell>7 (100)</cell><cell>7 (100)</cell></row><row><cell>Number of attempts performed</cell><cell>3.1 ± 0.9</cell><cell>3.7 ± 1.0</cell><cell>3.3 ± 1.1</cell><cell>3.1 ± 0.3</cell><cell>3.3 ± 1.1</cell><cell>4.1 ± 1.2</cell><cell>3.3 ± 1.1</cell><cell>2.7 ± 0.5 ⁎</cell><cell>3.2 ± 0.5</cell></row><row><cell>Number of successful attempts</cell><cell>2.3 ± 1.3*</cell><cell>3.4 ± 0.7</cell><cell>3.0 ± 1.5</cell><cell>3.0 ± 0.5</cell><cell>2.3 ± 1.6*</cell><cell>3.6 ± 0.7</cell><cell>3.0 ± 1.5</cell><cell>2.4 ± 0.5 ⁎</cell><cell>3.1 ± 0.7</cell></row></table><note><p><s>Definition of abbreviations: ARCN, CF Center at Airway Research Center North.</s><s>TLRC, CF Center at Translational Lung Research Center Heidelberg.</s><s>UGMLC, CF Center at Universities of Giessen and Marburg Lung Center.</s><s>Values are expressed as mean ± SD if not indicated otherwise.</s><s>⁎ P b 0.05 vs. TLRC.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3</head><label>3</label><figDesc><div><p><s>Distribution of LCI between study sites in infants and preschool children with CF. -12.6 6.5-9.3 6.6-12.6 6.1-9.6 Patients with abnormal LCI, n (%) 10 (23.3) 1 (12.5)</s><s>6 (28.6) 3 (21.4)</s><s>Definition of abbreviations: ARCN, CF Center at Airway Research Center North.</s><s>TLRC, CF Center at Translational Lung Research Center Heidelberg.</s><s>UGMLC, CF Center at Universities of Giessen and Marburg Lung Center.</s></p></div></figDesc><table><row><cell></cell><cell>Total</cell><cell>ARCN</cell><cell>TLRC</cell><cell>UGMLC</cell></row><row><cell>Participating patients, n</cell><cell>49</cell><cell>12</cell><cell>21</cell><cell>16</cell></row><row><cell cols="2">Patients with successful MBW, n 43</cell><cell>8</cell><cell>21</cell><cell>14</cell></row><row><cell>LCI mean ± SD</cell><cell cols="4">7.3 ± 1.2 7.1 ± 0.9 7.6 ± 1.3 7.0 ± 1.0</cell></row><row><cell>range</cell><cell>6.1</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>The authors thank the children and their families for their participation in the study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interest</head><p><s>This work was supported in part by the German Ministry for Education and Research (82DZL00401, 82DZL0040A1, 82DZL10106, 82DZL10501), the German Cystic Fibrosis Association Mukoviszidose e.V. (grant 15/01), the Dietmar Hopp Foundation and the Mukoviszidose Förderverein Giessen e.V.</s><s>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author contributions</head><p><s>Conception and design of the study: MS, MVK, LN, MAM; Acquisition, analysis and interpretation of data: MS, SYG, CJ, SB, IR, GD, MVK, LN, MAM; Drafting the article or revising it critically for important intellectual content: MS, SYG, CJ, SB, IR, GD, MVK, LN, MAM.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Appendix A. Supplementary data</head><p><s>Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.jcf.2017.08.001.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Cystic fibrosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Elborn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="page" from="2519" to="2531" />
			<date type="published" when="2016">2016. 10059</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">CFTR: cystic fibrosis and beyond</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Mall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hartl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1042" to="1054" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Future directions in early cystic fibrosis lung disease research: an NHLBI workshop report</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Ramsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Banks-Schlegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Accurso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Boucher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Cutting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Engelhardt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="887" to="892" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rosenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Kerby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Brumback</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Kloster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Acton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">182</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1387" to="1397" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Thia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Hoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Aurora</forename><forename type="middle">P</forename><surname>Wade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thorax</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="910" to="917" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">PRAGMA-CF. a quantitative structural lung disease computed tomography outcome in young children with cystic fibrosis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Rosenow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Oudraad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Turkovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>De Bruijne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">191</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1158" to="1165" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Wielpütz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Puderbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kopp-Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fritzsching</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Sommerburg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">189</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="956" to="965" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Early detection and sensitive monitoring of CF lung disease: prospects of improved and safer imaging</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Mall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Graeber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Sommerburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Kauczor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Wielputz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Pulmonol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">S44</biblScope>
			<biblScope unit="page" from="S49" to="60" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Belessis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dixon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hawkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Macdonald</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="862" to="873" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Hoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Thia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chudleigh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thorax</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="874" to="881" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Multiple breath washout is feasible in the clinical setting and detects abnormal lung function in infants and young children with cystic fibrosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Stahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Joachim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Blessing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hämmerling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Sommerburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Latzin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Respiration</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="357" to="363" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Comparison of lung clearance index and magnetic resonance imaging for assessment of lung disease in children with cystic fibrosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Stahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Wielputz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Graeber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Joachim</forename><forename type="middle">C</forename><surname>Sommerburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Kauczor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">195</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="349" to="359" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function</title>
		<author>
			<persName><forename type="first">R</forename><surname>Amin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Subbarao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jabar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Balkovec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kerrigan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thorax</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="379" to="383" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Amin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Subbarao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Lou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jabar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Balkovec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jensen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="806" to="812" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline</title>
		<author>
			<persName><forename type="first">P</forename><surname>Subbarao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stanojevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rosenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Davis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="456" to="460" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Lung clearance index and structural lung disease on computed tomography in early cystic fibrosis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Ramsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rosenow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Turkovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Skoric</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Banton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Adams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">193</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="60" to="67" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sheridan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Elborn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Respir Med</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="630" to="638" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Lumacaftor/Ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Milla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ratjen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Marigowda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Waltz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rosenfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Progression of lung disease in preschool patients with cystic fibrosis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Stanojevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Retsch-Bogart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Webster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Progressive ventilation inhomogeneity in infants with cystic fibrosis after pulmonary infection</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ranganathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Turkovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Robins-Browne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1680" to="1690" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The German centre for lung research -translational research for the prevention, diagnosis and treatment of respiratory diseases</title>
		<author>
			<persName><forename type="first">W</forename><surname>Seeger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Welte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Eickelberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Rabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Keller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pneumologie</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="464" to="469" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">The growth rate of healthy children in the first 16 years: Bonn-Dortmund longitudinal developmental study</title>
		<author>
			<persName><forename type="first">I</forename><surname>Brandt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Reinken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Klin Padiatr</title>
		<imprint>
			<biblScope unit="volume">200</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="451" to="456" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Perzentile für den Body mass index für das kindes-und jugendalter unter heranziehung verschiedener deutscher stichproben</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kromeyer-Hauschild</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wabitsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Geller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ziegler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Geiß</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Hesse</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Monatsschr Kinderheilkd</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="807" to="818" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Use of chloral hydrate for sedation in children</title>
	</analytic>
	<monogr>
		<title level="j">American Academy of Pediatrics Committee on Drugs and Committee on Environmental Health</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="471" to="473" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note>Pediatrics</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Respiratory function measurements in infants: measurement conditions. Working Group of the European Respiratory Society and the</title>
		<author>
			<persName><forename type="first">C</forename><surname>Gaultier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Fletcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Beardsmore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>England</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Motoyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1057" to="1066" />
			<date type="published" when="1995">1995</date>
			<publisher>American Thoracic Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Normative data for lung function and exhaled nitric oxide in unsedated healthy infants</title>
		<author>
			<persName><forename type="first">O</forename><surname>Fuchs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Latzin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Thamrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Stern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Frischknecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Singer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1208" to="1216" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Consensus statement for inert gas washout measurement using multipleand single-breath tests</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Latzin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Verbanck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Horsley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gappa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="507" to="522" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">False normal lung clearance index in infants with cystic fibrosis due to software algorithms</title>
		<author>
			<persName><forename type="first">P</forename><surname>Anagnostopoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yammine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Korten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kieninger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Mack</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Pulmonol</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="970" to="977" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Multiple breath washout analysis in infants: quality assessment and recommendations for improvement</title>
		<author>
			<persName><forename type="first">P</forename><surname>Anagnostopoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Egger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Usemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Gorlanova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Meas</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="L1" to="L15" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Correlation, regression, and repeated data</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">308</biblScope>
			<biblScope unit="issue">6933</biblScope>
			<biblScope unit="page">896</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Cystic fibrosis in young children: a review of disease manifestation, progression, and response to early treatment</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Vandevanter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Kahle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>O'sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sikirica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Hodgkins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cyst Fibros</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="147" to="157" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Early cystic fibrosis lung disease: role of airway surface dehydration and lessons from preventive rehydration therapies in mice</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Mall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Graeber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhou-Suckow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Biochem Cell Biol</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="174" to="179" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Is the raised volume rapid thoracic compression technique ready for use in clinical trials in infants with cystic fibrosis?</title>
		<author>
			<persName><forename type="first">S</forename><surname>Matecki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>De Boeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Bourgeois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zielen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Braggion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cyst Fibros</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="10" to="20" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Feasibility of lung clearance index in a clinical setting in pre-school children</title>
		<author>
			<persName><forename type="first">B</forename><surname>Downing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Irving</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bingham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Saglani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1074" to="1080" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Measurement of lung volume and ventilation distribution with an ultrasonic flow meter in healthy infants</title>
		<author>
			<persName><forename type="first">A</forename><surname>Schibler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Businger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Reinmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Wildhaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cernelc</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="912" to="918" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
